Please use this identifier to cite or link to this item: 192.168.6.56/handle/123456789/2560
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnamaris M. Colberg-Poleyen
dc.contributor.editorM, Anamaris-
dc.date.accessioned2018-09-19T07:49:06Z-
dc.date.available2018-09-19T07:49:06Z-
dc.date.issued2004-
dc.identifier.isbn978-3-906980-53-9-
dc.identifier.urihttp://10.6.20.12:80/handle/123456789/2560-
dc.descriptionIn developed countries, human cytomegalovirus (CMV) is the major infectious cause of congenital birth defects including microcephaly, mental retardation, sensorineural hearing loss, and intrauterine growth restriction. Nonetheless, because of the potential for teratogenicity and toxic effects, no prenatal therapeutic treatment is currently approved by the Food and Drug Administration for congenital CMV infection. Therefore there is great interest in understanding CMV growth and blocking or altogether preventing CMV infectionen
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.subjectCMVen_US
dc.titleRecent CMV Researchen_US
dc.typeBooken_US
Appears in Collections:Veterinary Medicine

Files in This Item:
File Description SizeFormat 
115,2014.pdf.pdf42.47 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.